The Global Medical Blood Lancet Market is projected to reach USD 1,552.9 million by the end of 2024 and grow steadily towards an expected value of USD 3,682.8 million by 2033 with compound annual ...

A 10-year JAMA study of more than 6,000 adults found heart calcium scans added little for most people but helped those at borderline or intermediate risk. Rural hospital leaders say the $50 billion ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric clinical-grade blood collection solutions, today announced it received CE Mark certification for its Tasso+™ device, a ...

The FDA has issued new risk classification orders for two series of products, including in vitro diagnostics for hepatitis C, two of which the agency down-regulated from class III to class II. However ...

In a proposed order set to be published Thursday, FDA explains its justifications for its suggested reclassification of blood lancets from Class I to the more stringent Class II and Class III groups.

Most people who live with diabetes, whether type 1 or type 2, have to test their blood glucose levels daily, some even more frequently. Monitoring blood sugar amounts gives patients and doctors the ...